腹腔鏡脾切除術(shù)治療肝硬化所致脾功能亢進的臨床研究
[Abstract]:Objective to investigate retrospectively the clinical data of laparoscopic splenectomy and traditional open splenectomy in the treatment of liver cirrhosis hypersplenism. The feasibility, safety, advantages and disadvantages of laparoscopic splenectomy for patients with liver cirrhosis and hypersplenism were discussed. Methods from January 2012 to December 2015 in Anqing Municipal Hospital affiliated to Anhui Medical University, 23 cases of laparoscopic hypersplenectomy of liver cirrhosis and 23 cases of traditional open hepatocirrhosis were retrospectively analyzed and compared with those from January 2012 to December 2015 in the general surgery department of Anqing Municipal Hospital affiliated to Anhui Medical University. Clinical data of patients undergoing splenectomy for hypersplenism. Two groups of different clinical data (gender, mean age, average weight, etc.), surgical-related indicators (such as operation time, pain degree of incision, extubation time, postoperative hospital stay, spleen size), liver function, inflammatory reaction, and so on, were compared and analyzed between the two groups of clinical data (gender, mean age, average weight, etc.) Immune function, etc. Results there were no perioperative death cases in both groups, 23 cases in laparoscopy group, 8 cases in male and 15 cases in female, and 23 cases in laparotomy group, including 10 cases in male and 13 cases in female. Comparative analysis of general clinical data, such as the average weight, age, sex and other comparable, P0.05, there was no significant difference between the two groups. The operative indexes were: incision length, drainage tube indwelling time, postoperative hospital stay, average times of analgesia were 4.86 鹵0.49 cm, 4.77 鹵1.52 days, 7.79 鹵1.28 days, 1.91 鹵0.67 times, respectively. In the open group, 15.54 鹵1.30cm, 6.76 鹵2.41 days, 11.03 鹵2.73 days, 4.00 鹵0.85 times, respectively. Compared with the traditional laparotomy group, the above-mentioned indexes showed statistically significant difference (P0.05), significantly decreased. The average operation time was 101.38 鹵26.25 minutes in laparoscopy group and 76.14 鹵15.36 minutes in traditional laparotomy group, the difference was statistically significant (P0.05), the former was significantly longer than the latter. In the abdominal group, the volume of bleeding, the volume of blood transfusion and the maximum diameter of spleen resection were 156.42 鹵36.43ml, 243.48 鹵119.95ml, 15.88鹵 1.23 cm;, respectively, in the abdominal group were 156.42 鹵36.43ml, 243.48 鹵119.95ml and 15.88鹵 1.23 cm;. In the open group, 180.50 鹵48.19 ml, 260.15 鹵102.78 ml, 16.86 鹵1.50 cm, respectively, there was no significant difference (P0.05). The incidence of postoperative complications was 13.04% in the laparoscopy group and 17.39% in the open group. The incidence of postoperative complications in the laparoscopy group was lower than that in the laparotomy group, but there was no significant difference (P0.05). Liver function: on the 1st day before operation, there was no significant difference in ALT,AST,Tbil,Dbil and other indexes between the two groups (P0.05). On the 1st and 7th day after operation, the ALT,AST,Tbil,Dbil of the two groups was higher than that of the preoperative group, and that of the laparoscopy group was lower than that of the open group (P0.05). Inflammatory factors and immune function: before operation, there was no significant difference in WBC,CRP,CD4, CD8, CD4 / CD8 between the two groups (P0.05); On the 1st and 3rd day after operation, WBC,CRP,CD8 increased, CD4, CD4 / CD8 decreased, endoscopic WBC,CRP,CD8 was lower, CD4, CD4 / CD8 were higher in the two groups than those in the open group (P0.05). Conclusion Laparoscopic splenectomy is superior to laparotomy in the treatment of hypersplenism caused by liver cirrhosis. The incision is smaller during the operation, and the incision recovers quickly after the operation. The time of indwelling the drainage tube in the body is relatively short and the hospitalization time is shorter than that of the laparoscopic splenectomy in the treatment of hypersplenism caused by cirrhosis. It can effectively reduce the incidence of inflammation. This method is as safe and feasible as the previous open hand, and the effect is the same as that after the previous open operation, but the operation time is relatively long. In terms of long-term curative effect, it is necessary to draw a conclusion through the follow-up at the later stage.
【學位授予單位】:安徽醫(yī)科大學
【學位級別】:碩士
【學位授予年份】:2017
【分類號】:R657.31
【相似文獻】
相關(guān)期刊論文 前10條
1 王躍東 ,吳金民 ,李偉 ,張強 ,楊進 ,張暉 ,王先發(fā);腹腔鏡脾切除術(shù)的探討[J];中華外科雜志;2002年04期
2 馮澤榮;腹腔鏡脾切除術(shù)的研究進展[J];醫(yī)學文選;2002年06期
3 王奕,張浩,胡理明,陳萍,王躍東;腹腔鏡脾切除術(shù)治療特發(fā)性血小板減少性紫癜[J];中華外科雜志;2003年10期
4 李學明,李勇,徐小躍,劉逸,范麗萍,張敏;腹腔鏡脾切除術(shù)二例報告[J];江西醫(yī)學院學報;2003年05期
5 印慨,鄭成竹,柯重偉,李際輝,華積德;腹腔鏡脾切除術(shù)治療原發(fā)性血小板減少性紫癜29例報告[J];中國實用外科雜志;2004年04期
6 鄭曉風,蔣飛照,張啟瑜;腹腔鏡脾切除術(shù)七例[J];中華肝膽外科雜志;2004年05期
7 彭和平,李永國,邵子力,盧海武,梁建中;腹腔鏡脾切除術(shù)治療特發(fā)性血小板減少性紫癜臨床應用研究[J];血栓與止血學;2005年03期
8 李學明;肖衛(wèi)東;鄧小榮;張榮艷;楊贛萍;;腹腔鏡脾切除術(shù)治療特發(fā)性血小板減少性紫癜(附14例報告)[J];江西醫(yī)藥;2007年04期
9 傅永清;周劍;裘華森;顧文揚;李寧;;腹腔鏡脾切除術(shù)治療特發(fā)性血小板減少性紫癜[J];中國中西醫(yī)結(jié)合外科雜志;2007年03期
10 劉強;楊建青;褚光平;;腹腔鏡脾切除術(shù)治療特發(fā)性血小板減少性紫癜15例分析[J];中國內(nèi)鏡雜志;2007年11期
相關(guān)會議論文 前10條
1 戴啟強;王愛東;方哲平;;腹腔鏡脾切除術(shù)20例治療體會[A];2009年浙江省外科學學術(shù)年會論文匯編[C];2009年
2 傅永清;周劍;顧文揚;裘華森;任燕燕;張U,
本文編號:2451367
本文鏈接:http://sikaile.net/yixuelunwen/waikelunwen/2451367.html